{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:03:17Z","timestamp":1770814997984,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.thromres.2013.06.007","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T04:18:07Z","timestamp":1372738687000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Coagulation Factors and Recurrence of Ischemic and Bleeding Adverse Events in Patients with Acute Coronary Syndromes"],"prefix":"10.1016","volume":"132","author":[{"given":"Gianluca","family":"Campo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Pavasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Pollina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Tebaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.06.007_bb0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2012.11.002","article-title":"The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology","volume":"60","author":"Laslett","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.thromres.2013.06.007_bb0010","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/archinternmed.2011.536","article-title":"Prognostic impact of hospital readmissions after primary percutaneous coronary intervention","volume":"171","author":"Campo","year":"2011","journal-title":"Arch Intern Med"},{"issue":"25","key":"10.1016\/j.thromres.2013.06.007_bb0015","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1161\/CIRCULATIONAHA.108.833236","article-title":"Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention","volume":"119","author":"Valgimigli","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.thromres.2013.06.007_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11239-010-0457-5","article-title":"Poor response to clopidogrel: current and future options for its management","volume":"30","author":"Campo","year":"2010","journal-title":"J Thromb Thrombolysis"},{"issue":"22","key":"10.1016\/j.thromres.2013.06.007_bb0025","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.thromres.2013.06.007_bb0030","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MBC.0b013e328355111f","article-title":"Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients","volume":"23","author":"Campo","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"17","key":"10.1016\/j.thromres.2013.06.007_bb0035","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/eurheartj\/ehm224","article-title":"Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis","volume":"28","author":"Murphy","year":"2007","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.thromres.2013.06.007_bb0040","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.thromres.2013.06.007_bb0045","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","article-title":"Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial","volume":"295","author":"Yusuf","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.thromres.2013.06.007_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.thromres.2013.06.007_bb0055","first-page":"35","article-title":"Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease","volume":"47","author":"Espinosa","year":"2006","journal-title":"Invest Clin"},{"issue":"2","key":"10.1016\/j.thromres.2013.06.007_bb0060","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1160\/TH07-08-0523","article-title":"Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study","volume":"99","author":"Carty","year":"2008","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.thromres.2013.06.007_bb0065","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.amjcard.2012.11.060","article-title":"Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease","volume":"111","author":"Ndrepepa","year":"2013","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.thromres.2013.06.007_bb0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.thromres.2009.02.017","article-title":"G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece","volume":"125","author":"Rallidis","year":"2010","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.thromres.2013.06.007_bb0075","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1538-7836.2008.03266.x","article-title":"Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke","volume":"7","author":"Siegerink","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.06.007_bb0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2350-11-28","article-title":"Fibrinogen beta variants confer protection against coronary artery disease in a Greek case\u2013control study","volume":"11","author":"Theodoraki","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.thromres.2013.06.007_bb0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/cvr\/cvp066","article-title":"Is thrombin a key player in the 'coagulation-atherogenesis' maze?","volume":"82","author":"Borissoff","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"9511","key":"10.1016\/j.thromres.2013.06.007_bb0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(06)68263-9","article-title":"Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls","volume":"367","author":"Ye","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.thromres.2013.06.007_bb0095","first-page":"1134","article-title":"G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome","volume":"89","author":"Burzotta","year":"2004","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.thromres.2013.06.007_bb0100","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/j.1538-7836.2010.03982.x","article-title":"The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease","volume":"8","author":"Mannucci","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2013.06.007_bb0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.carpath.2012.03.002","article-title":"Lack of association between factor V Leiden and prothrombin G20210A polymorphisms in Tunisian subjects with a history of myocardial infarction","volume":"22","author":"Berredjeb Ben Slama","year":"2013","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.thromres.2013.06.007_bb0110","doi-asserted-by":"crossref","first-page":"594986","DOI":"10.1155\/2012\/594986","article-title":"Factor V Leiden and inflammation","volume":"2012","author":"Perez-Pujol","year":"2012","journal-title":"Thrombosis"},{"issue":"14","key":"10.1016\/j.thromres.2013.06.007_bb0115","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199504063321403","article-title":"Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men","volume":"332","author":"Ridker","year":"1995","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.thromres.2013.06.007_bb0120","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1046\/j.1538-7836.2003.00424.x","article-title":"A functional haplotype in the 5\u2019 flanking region of the factor VII gene is associated with an increased risk of coronary heart disease","volume":"1","author":"Carew","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.thromres.2013.06.007_bb0125","first-page":"789","article-title":"Effect of lipid-lowering treatment on factor VII profile in hyperlipidemic patients","volume":"84","author":"Porreca","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.06.007_bb0335","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1056\/NEJM200009143431104","article-title":"Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease","volume":"343","author":"Girelli","year":"2000","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.thromres.2013.06.007_bb0140","first-page":"774","article-title":"Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studies","volume":"343","author":"Pinotti","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2013.06.007_bb0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MBC.0b013e3281a3057f","article-title":"Coagulation factor VII and inflammatory markers in patients with coronary heart disease","volume":"18","author":"Ekstr\u00f6m","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1016\/j.thromres.2013.06.007_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM199801083380202","article-title":"Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction","volume":"338","author":"Iacoviello","year":"1998","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.thromres.2013.06.007_bb0155","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood.V93.10.3432.410k16_3432_3441","article-title":"Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration","volume":"93","author":"van 't Hooft","year":"1999","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2013.06.007_bb0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1160\/TH04-09-0616","article-title":"Influence of factor VII gene polymorphisms and environmental factors on plasma coagulation factor VII concentrations in middle-aged women with and without manifest coronary heart disease","volume":"93","author":"Eriksson-Berg","year":"2005","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.thromres.2013.06.007_bb0165","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1538-7836.2005.01232.x","article-title":"Factor VII gene polymorphisms are not associated with myocardial infarction in young women","volume":"3","author":"Peyvandi","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2013.06.007_bb0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1076029607308875","article-title":"Temporal and genotype-driven variation of factor VII levels in patients with acute myocardial infarction","volume":"15","author":"Ferraresi","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"issue":"12","key":"10.1016\/j.thromres.2013.06.007_bb0175","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.ATV.0000247249.82030.94","article-title":"Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events","volume":"26","author":"Campo","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.thromres.2013.06.007_bb0180","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1160\/TH07-08-0499","article-title":"Factor XIa and tissue factor activity in patients with coronary artery disease","volume":"99","author":"Butenas","year":"2008","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.thromres.2013.06.007_bb0185","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1538-7836.2009.03544.x","article-title":"Genetic variants associated with deep vein thrombosis: the F11 locus","volume":"7","author":"Li","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.thromres.2013.06.007_bb0190","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.thromres.2011.06.010","article-title":"Circulating activated FXI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events","volume":"128","author":"Undas","year":"2011","journal-title":"Thromb Res"},{"issue":"11","key":"10.1016\/j.thromres.2013.06.007_bb0195","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1161\/01.ATV.20.11.2489","article-title":"Activation of clotting factor XI and IX in patients with acute myocardial infarction","volume":"20","author":"Minnema","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.thromres.2013.06.007_bb0200","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1538-7836.2003.00195.x","article-title":"Inherited factor XI deficiency confers no protection against acute myocardial infarction","volume":"1","author":"Salomon","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.thromres.2013.06.007_bb0205","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.thromres.2012.05.004","article-title":"The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis","volume":"130","author":"Lunghi","year":"2012","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.thromres.2013.06.007_bb0210","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/j.1538-7836.2007.02687.x","article-title":"The plasma kallikrein\u2013kinin system and risk of cardiovascular disease in men","volume":"5","author":"Govers-Riemslag","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"13","key":"10.1016\/j.thromres.2013.06.007_bb0215","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2005-12-023697","article-title":"Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII","volume":"108","author":"Doggen","year":"2006","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.thromres.2013.06.007_bb0220","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/CIRCULATIONAHA.110.943738","article-title":"Intrinsic coagulation activation and the risk of arterial thrombosis in young women","volume":"122","author":"Siegerink","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2013.06.007_bb0225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1538-7836.2008.02839.x","article-title":"Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk","volume":"6","author":"Bach","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.thromres.2013.06.007_bb0230","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1160\/TH05-06-0453","article-title":"Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction","volume":"94","author":"Rold\u00e1n","year":"2005","journal-title":"Thromb Haemost"},{"issue":"1\u20132","key":"10.1016\/j.thromres.2013.06.007_bb0235","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2119\/2006-00049.Gemmati","article-title":"Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients","volume":"13","author":"Gemmati","year":"2007","journal-title":"Mol Med"},{"issue":"3","key":"10.1016\/j.thromres.2013.06.007_bb0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajh.1104","article-title":"A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases","volume":"67","author":"Gemmati","year":"2001","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.thromres.2013.06.007_bb0245","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-2141.2003.04047.x","article-title":"Is the factor XIII 34Val\/Leu polymorphism a protective factor for cerebrovascular disease?","volume":"120","author":"Endler","year":"2003","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.thromres.2013.06.007_bb0250","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0002-9394(02)01812-3","article-title":"Recurrent episodes of spontaneous subconjunctival hemorrhage in patients with factor XIII Val34Leu mutation","volume":"134","author":"Incorvaia","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.thromres.2013.06.007_bb0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.0000047062.03282.A3","article-title":"Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism","volume":"107","author":"Undas","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.06.007_bb0265","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1046\/j.1538-7836.2003.00352.x","article-title":"Two factor XIII gene polymorphisms associated with a structural and functional defect and the risk of myocardial infarction in men","volume":"1","author":"Doggen","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.thromres.2013.06.007_bb0270","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.thromres.2006.12.013","article-title":"Modulation of the risk of coronary sclerosis\/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population","volume":"120","author":"Bereczky","year":"2007","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.thromres.2013.06.007_bb0275","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0049-3848(97)00234-X","article-title":"Effects on coronary angioplasty on monocyte tissue factor response in patients with stable or unstable angina","volume":"88","author":"Agrau","year":"1997","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.thromres.2013.06.007_bb0280","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.105.567297","article-title":"Tissue factor in cardiovascular disease: molecular mechanisms and clinical implications","volume":"113","author":"Steffel","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.thromres.2013.06.007_bb0285","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.ATV.0000085629.23209.AA","article-title":"Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs","volume":"23","author":"Camera","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9054","key":"10.1016\/j.thromres.2013.06.007_bb0340","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(96)11189-2","article-title":"Tissue Factor antigen and activity in human coronary atherosclerotic plaques","volume":"349","author":"Ardissino","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.thromres.2013.06.007_bb0300","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.ATV.20.3.892","article-title":"Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies","volume":"20","author":"Arnaud","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.thromres.2013.06.007_bb0305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2004.07.006","article-title":"Tissue factor promotor polymorphism \u2212603 A\/G is associated with myocardial infarction","volume":"177","author":"Ott","year":"2004","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.thromres.2013.06.007_bb0310","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.CIR.0000050621.67499.7D","article-title":"Role of risk factor in the modulation of tissue factor activity and blood thrombogenicty","volume":"107","author":"Sambola","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2013.06.007_bb0315","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0002-9149(97)00801-1","article-title":"Comparison of plasma tissue factor levels in unstable and stable angina pectoris","volume":"81","author":"Misumi","year":"1998","journal-title":"Am J Cardiol"},{"issue":"13","key":"10.1016\/j.thromres.2013.06.007_bb0320","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/01.CIR.0000091082.75419.9F","article-title":"Elevated whole-blood tissue factor prococoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation","volume":"108","author":"Tutar","year":"2003","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.thromres.2013.06.007_bb0325","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1161\/01.ATV.0000191637.48129.9b","article-title":"Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes","volume":"25","author":"M\u00e4larstig","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.thromres.2013.06.007_bb0330","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1253\/circj.CJ-08-0465","article-title":"Important regulatory role of activated platelet-derived procoagulant activity in the propagation of thrombi formed under arterial blood flow conditions","volume":"73","author":"Tamura","year":"2009","journal-title":"Circ J"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813002582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813002582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T13:38:36Z","timestamp":1596029916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384813002582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0049384813002582"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.06.007","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation Factors and Recurrence of Ischemic and Bleeding Adverse Events in Patients with Acute Coronary Syndromes","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}